Bill
Bill > HR5686
US HR5686
US HR5686Medicare CHOICE Act of 2018 Medicare Clear Health Options in Care for Enrollees Act of 2018
summary
Introduced
05/07/2018
05/07/2018
In Committee
05/16/2018
05/16/2018
Crossed Over
Passed
Dead
12/31/2018
12/31/2018
Introduced Session
115th Congress
Bill Summary
Medicare CHOICE Act of 2018 Medicare Clear Health Options in Care for Enrollees Act of 2018 This bill requires Medicare and Medicare Advantage prescription drug plan (PDP) sponsors to annually disclose information to enrollees about: (1) the adverse effects of prolonged opioid use; and (2) the plan's coverage of nonpharmacological therapies, devices, and non-opioid medications. PDP sponsors may limit disclosure to a subset of enrollees (such as those who were prescribed an opioid in the previous two-year period).
AI Summary
This bill, the Medicare Clear Health Options in Care for Enrollees (CHOICE) Act of 2018, requires Medicare and Medicare Advantage prescription drug plans to annually disclose information to enrollees about the adverse effects of prolonged opioid use, as well as the plan's coverage of non-pharmacological therapies, devices, and non-opioid medications used to treat pain. The bill allows plan sponsors to limit this disclosure to a subset of enrollees, such as those who have been prescribed opioids in the previous two years.
Committee Categories
Business and Industry, Health and Social Services
Sponsors (7)
Erik Paulsen (R)*,
Marsha Blackburn (R),
Chris Collins (R),
Brian Fitzpatrick (R),
Ron Kind (D),
Conor Lamb (D),
Greg Walden (R),
Last Action
Placed on the Union Calendar, Calendar No. 575. (on 06/12/2018)
Official Document
bill text
bill summary
Loading...
bill summary
Loading...
bill summary
Loading...